Source - SMW
Numis today reaffirms its buy investment rating on Circassia Pharmaceuticals Plc (LON:CIR) and set its price target at 150p.

Related Charts

Circassia Pharmaceuticals (CIR)

+1.00p (+1.09%)
delayed 18:15PM